NKG2D-expressing immune cells are decreased in patients with cervical cancer and precursor lesions

Three color flow cytometry analysis to detect CD3, CD56 and NKG2D was carried out on PBMC to determine the percentage of NKG2D-positive cells. NKG2D-expressing NK cells (CD56CD3population); NKG2D-expressing T cells (CD56CD3population). The box plots represent each study group. Medians are represented as thick horizontal lines, 25and 75percentiles as boxes and 10and 90percentiles as whiskers. *Extreme values.<p><b>Copyright information:</b></p><p>Taken from "Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions"</p><p>http://www.biomedcentral.com/1471-2407/8/16</p><p>BMC Cancer 2008;8():16-16.</p><p>Published online 21 Jan 2008</p><p>PMCID:PMC2270854.</p><p>